Behind genetic analysis, the distribution network value

Monday 10th November 2008
Cepheid CEO John Bishop augments its UK based direct sales by acquisition

Cepheid, the Sunnyvale-based, California on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets is to acquire Stretton Scientific, a UK-based distributor of diagnostic and monitoring equipment, for around £1.2m ($1.9m) in a move that highlights distribution in the hightech global world.

Privately held Stretton already distributes Cepheid’s SmartCycler system to customers, including the National Health Service, throughout the UK. Back in October,  Cepheid's Xpert MRSA test,  proved to be 100% accurate, allowing doctors at the Birmingham's Children's Hospital to identify MRSA carriers in under an hour

The acquisition of Stretton is expected to “augment our newly established UK-based direct sales team,” said Cepheid CEO John Bishop.  Cepheid said that it will pay the $1.9m acquisition price in cash.

It expects to close the transaction early this month, subject to customary closing conditions. Cepheid noted that the deal is not expected to have a material impact on its fourth-quarter financial results.



Custom Search

Scotland, Computer News in Scotland, Technology News in Scotland, Computing in Scotland, Web news in Scotland computers, Internet, Communications, advances in communications, communications in Scotland, Energy, Scottish energy, Materials, Biomedicine, Biomedicine in Scotland, articles in Biomedicine, Scottish business, business news in Scotland.

Website : beachshore